Gordon Cook, PhD, DSc^1,2*, Charlotte Pawlyn, PhD³, Kara-Louise Royle^4*, Ethan R Senior^5*, Dax Everritt^6*, Jenny Bird^7*, Stella Bowcock^8*, Bryony Dawkins, MSc^9*, Mark Drayson^10*, Sharon Gillson, BSc^5*, Catherine Olivier^1*, Matthew W. Jenner^11*, John Jones^12*, Martin F Kaiser, MD¹³, Bhuvan Kishore^14*, David Meads, PhD^9*, Neil Rabin^15*, Roger G Owen, MD, MRCP, FRCPath^16*, Ruth M de Tute, MSc, PhD, FRCPath^16*, Christopher Parrish, MBBChir, MRCP, FRCPath, MA, PhD⁴, Alan Chant^17*, David A. Cairns, PhD^4* and Graham Jackson, MD^18*

¹Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
²CRUK Clinical Trials Unit, Leeds Institute of Clinical Tial Research, Leeds Myeloma Research Group and NIHR Leeds Biomedical Research Centre, Leeds, United Kingdom
³Institute of Cancer Research, Sutton, United Kingdom
⁴Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
⁵Leeds Institute of Clinical Trials Research, Cancer Research UK Clinical Trials Unit, Leeds, United Kingdom
⁶CRUK CTU, Leeds Insitute of Clinical Trial Research, University of Leeds, Leeds, United Kingdom
⁷Department of Haematology, University Hospitals Bristol NHS Foundation Trust, Cambridge, GBR
⁸King’s College Hospital, London, United Kingdom
⁹University of Leeds, Academic Unit of Health Economics, Leeds, United Kingdom
¹⁰University of Birmingham, Institute of Immunology and Immunotherapy, Birmingham, United Kingdom
¹¹University Hospital Southampton, Southampton, United Kingdom
¹²East Sussex Healthcare NHS Trust, London, United Kingdom
¹³The Institute of Cancer Research, London, ENG, United Kingdom
¹⁴Heartofengland NHS FT, Birmingham, GBR
¹⁵Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
¹⁶HMDS, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
¹⁷Patient and Public Contributor, NA, United Kingdom
¹⁸University of Newcastle, Department of Haematology, Newcastle, United Kingdom

Pieter Sonneveld, MD¹, Meletios A. Dimopoulos, MD², Meral Beksac, MD^3,4, Bronno van der Holt, PhD^1,5*, Francesca Gay, MD, PhD^6*, Heinz Ludwig, MD⁷, Sonja Zweegman, MD, PhD⁸, Vladimir Maisnar, MD, PhD^9*, Maria Teresa Petrucci, MD^10*, Paolo Corradini, MD¹¹, Francesca Patriarca, MD, PhD^12*, Angelo Belotti, MD^13*, Micol Quaresima, MD^14*, Mariella Grasso, MD^15*, Massimo Offidani, MD^16*, Laura Paris, MD^17*, Anna Marina Liberati, MD¹⁸, Markus Hansson, MD, PhD^19*, Heleen Visser-Wisselaar, PhD^5*, Giulia Fumero, MSc^20*, Renato Zambello, MD^21*, Paula F Ypma, MD, PhD^22*, Anna Pascarella, MD^23*, Niels Frost Andersen, MD, PhD^24*, Alexandra Croockewit, MD, PhD^25*, Mario Boccadoro, MD²⁰ and Michele Cavo, MD^26,27*

¹Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
²Hematology and Medical Oncology, Department of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, Athens, Greece
³Department of Hematology, Ankara University Faculty of Medicine, Ankara, Turkey
⁴Department of Hematology, Ankara Liv Hospital, Istinye University, Ankara, Turkey
⁵HOVON Foundation, Rotterdam, Netherlands
⁶Division of Hematology, AOU Città della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy
⁷Wilhelminen Cancer Research Institute, c/o Department of Medicine I, Clinic Ottakring, Vienna, Austria
⁸Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
⁹4th Department of Medicine - Haematology, Charles University Hospital and Faculty of Medicine Hradec Kralove, Hradec Kralove, Czech Republic
¹⁰Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
¹¹Fondazione IRCCS Istituto Nazionale dei Tumori Milano, Università di Milano, Milano, Italy
¹²Hematologic Clinic and Transplant Center, University Hospital of Central Friuli, DMED, University of Udine, Udine, Italy
¹³Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
¹⁴Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy
¹⁵Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy
¹⁶AOU delle Marche, Ancona, Italy
¹⁷Division of Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy
¹⁸A.O. Santa Maria di Terni – Università degli Studi di Perugia, Terni–Perugia, Italy
¹⁹Department of Hematology, Skåne University Hospital, Lund, Sweden
²⁰European Myeloma Network, EMN, Italy
²¹Department of Medicine (DIMED), Hematology and Clinical Immunology, Padua University, Padua, Italy
²²Department of Hematology, HagaZiekenhuis, Den Haag, Netherlands
²³UOC Ematologia, Ospedale dell'angelo, Venezia Mestre, Italy
²⁴Department of Haematology, Aarhus University Hospital, Aarhus, Denmark
²⁵Department of Hematology, Radboud University Medical Centre, Nijmegen, Netherlands
²⁶IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy
²⁷Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy

Laahn Foster, MD^1*, Larry D Anderson Jr., MD, PhD², Alfred Chung, MD³, Chakra Chaulagain, MD⁴, Erin M. Pettijohn, MD⁵, Andrew J. Cowan, MD^6*, Caitlin Costello, MD⁷, Sarah M. Larson, MD⁸, Douglas W. Sborov, MD, MS⁹, Kenneth H. Shain, MD, PhD¹⁰, Rebecca Silbermann¹¹, Peter M. Voorhees, MD¹², Maria Krevvata, PhD^13*, Huiling Pei, PhD^14*, Sharmila Patel, PhD^15*, Vipin Khare, MD^15*, Annelore Cortoos, MD^15*, Robin Carson, MD¹³, Thomas S. Lin, MD, PhD¹⁵ and Ashraf Z. Badros, MD, Ch.B.¹⁶

¹Division of Hematology Oncology, University of Virginia, Charlottesville, VA
²Myeloma, Waldenstrom’s, and Amyloidosis Program, Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
³Department of Medicine, University of California San Francisco, San Francisco, CA
⁴Department of Hematology and Oncology, Myeloma and Amyloidosis Program, Cleveland Clinic Florida, Weston, FL
⁵Cancer and Hematology Centers of Western Michigan, Grand Rapids, MI
⁶Division of Medical Oncology, Fred Hutch Cancer Center/University of Washington, Seattle, WA
⁷Moores Cancer Center at University of California San Diego, La Jolla, CA
⁸Division of Hematology and Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA
⁹Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
¹⁰Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
¹¹Knight Cancer Institute, Oregon Health & Science University, Portland, OR
¹²Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC
¹³Janssen Research & Development, LLC, Spring House, PA
¹⁴Janssen Research & Development, LLC, Titusville, NJ
¹⁵Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Horsham, PA
¹⁶Greenbaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD

Annemiek Broijl, PhD¹, Fredrik Schjesvold, MD, PhD^2,3, Abdel el Yaakoubi, MSc^4*, Djamila Issa, MD PhD^5*, Sonja Zweegman, MD, PhD⁶, Kon-Siong Jie^7*, Mario Boccadoro, MD⁸, Roman Hajek⁹, Bronno van der Holt, PhD^4*, Ruth Wester, MD, PhD^10* and Pieter Sonneveld, MD¹¹

¹Erasmus MC Cancer Institute, Rotterdam, Netherlands
²KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway
³Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway
⁴HOVON Foundation, Rotterdam, Netherlands
⁵Department of Internal Medicine, Jeroen Bosch Hospital, Den Bosch, Netherlands
⁶Amsterdam UMC, Department of Hematology, Netherlands, Amsterdam, Netherlands
⁷Zuyderland Medical Centre, Sittard-Geleen, Netherlands
⁸-, Torino, TO, Italy
⁹Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic
¹⁰Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
¹¹Erasmus MC Cancer Institute, Rotterdam, Zuid-Holland, Netherlands

Luciano J. Costa, MD, PhD¹, Fredrik Schjesvold, MD, PhD^2,3, Rakesh Popat, MBBS, PhD⁴, David Siegel^5*, Saad Z. Usmani, MD⁶, Syed Abbas Ali⁷, Michael P. Chu, MD⁸, Monique A. Hartley-Brown, MD⁹, Nizar J. Bahlis^10*, Albert Oriol^11*, Joaquín Martínez Lopez^12*, Enrique M. Ocio¹³, Karthik Ramasamy¹⁴, Donna Reece, MD¹⁵, Emma Searle^16*, Allison Gaudy^17*, Antonina Kurtova^17*, Wen Zhang^17*, Rafael Sarmiento^18*, August Dietrich¹⁹, Jessica Katz¹⁷, Michael Pourdehnad, MD¹⁷ and Paul G. Richardson⁹

¹Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
²Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway
³Department of Haematology, Oslo Myeloma Center, Oslo University Hospital, and KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway
⁴NIHR UCLH Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, United Kingdom
⁵John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
⁶Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD
⁸Department of Oncology, University of Alberta, Edmonton, AB, Canada
⁹Dana-Farber Cancer Institute, Boston, MA
¹⁰Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada
¹¹Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain
¹²Department of Hematology, Hospital 12 de Octubre, Complutense University, H12O-CNIO Clinical Research Unit, CIBERONC, Madrid, Spain
¹³Hospital Universitario Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain
¹⁴Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
¹⁵Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
¹⁶The Christie NHS Foundation Trust and University of Manchester, Manchester, United Kingdom
¹⁷Bristol Myers Squibb, Princeton, NJ
¹⁸Bristol Myers Squibb, Center for Innovation and Translational Research Europe (CITRE), Seville, Spain
¹⁹Research and Development, Bristol Myers Squibb, Princeton, NJ

Maria- Victoria Mateos¹, Bruno Paiva, PhD^2*, Maria Teresa Cedena Romero, MD, PhD^3*, Noemi Puig, PhD⁴, Anna Sureda Balari⁵, Albert Oriol, MD, PhD^6*, Enrique M Ocio, MD, PhD^7*, Laura Rosiñol, MD, PhD^8*, Yolanda González-Montes, MD, PhD^9*, Joan Bargay, MD, PhD^10*, Esther Gonzalez Garcia, MD, PhD^11*, Miguel Teodoro Hernández Garcia, MD, PhD^12*, Angel Ramirez, MD, PhD^13*, Alexia Suarez-Cabrera, MD, PhD^14*, María-Jesús Blanchard, MD, PhD^15*, Sebastián Garzón, MD, PhD^16*, Luis Felipe Casado^17*, Valentin Cabanas Perianes, MD, PhD^18*, Jaime Perez de Oteyza^19*, Mercedes Gironella, MD^20*, Joaquin Martínez-López^21*, Ana-Isabel -Teruel, MD, PhD^22*, Pilar Delgado, MD, PhD^23*, Elena Prieto, MD, PhD^24*, Juan-Jose Lahuerta Palacios, MD, PhD^25*, Joan Bladé, MD, PhD^26* and Jesús F. San-Miguel, MD, PhD²⁷

¹Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Centro de Investigación del Cáncer (IBMCC-USAL,CSIC), Salamanca, Spain
²Cancer Center Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBER-ONC number CB16/12/00369 and CB16/12/00489, Pamplona, Spain
³Instituto de Investigación IMAS12, Madrid, Spain
⁴Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain
⁵Clinical Hematology Department, Institut Català d’Oncologia-Hospitalet, IDIBELL, Barcelona, Spain
⁶Hematology, Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain
⁷Hospital Universitario Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain
⁸Hematology, IDIBAPS, Hospital Clinic, Barcelona, ESP
⁹Hematology, Institut d'Oncologia Dr. Josep Trueta, Girona, Spain
¹⁰Hematology, Hospital Universitari Son Llàtzer, IdIsBa, Palma de Mallorca, Spain
¹¹Hematology, University Hospital Cabueñes, Gijón, Spain
¹²Hematology, Hospital Universitario de Canarias, Santa cruz de Tenerife, Spain
¹³Hematology, Hospital Central de Asturias, Oviedo, Spain
¹⁴Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas De Gran Canaria, Spain
¹⁵Hematology, Hospital Universitario Ramon y Cajal, Madrid, Spain
¹⁶Hematology, Hospital Universitario Jerez de la Frontera, Jerez de la Frontera, Cádiz, Spain
¹⁷Hematology, Hospital General Universitario de Toledo, Toledo, Spain
¹⁸Hematology, IMIB-Virgen de la Arrixaca University Hospital, University of Murcia, El Palmar, Murcia, Spain
¹⁹Clinical Hematology and Oncohematology, Hospital Universitario HM Sanchinarro, Madrid, Spain
²⁰Hematology, Hospital Universitari Vall d'Hebron, Barcelona, Spain
²¹Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain
²²Hematology, Hospital Clínico Universitario de Valencia, Valencia, Spain
²³Hematology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain
²⁴Hematology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
²⁵Hematology, Hospital Universitario 12 de Octubre, Imas12, CIBERONC, Madrid, Spain
²⁶Hematology, Hospital Clínic de Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona; and GEM/PETHEMA, Barcelona, Spain
²⁷Department of Hematology, Centre for Applied Medical Research, Cancer Center Clinica Universidad de Navarra, University of Navarra, IdiSNA, CIBERONC, Pamplona, Spain